Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1133191

registered interest
date	19/06/2019
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	Brexit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, when the Government last updated its published technical notices on the UK leaving the EU without a negotiated agreement; and whether his Department has plans to publish further updated technical notices.
tabling member constituency	Wolverhampton North East
tabling member printed	Emma Reynolds
uin	266735
answer	answer is ministerial correction date of answer 24/06/2019 answer text <p>The Department for Exiting the European Union coordinated the initial publication of 106 Technical Notices between August and October 2018. Departments are responsible for their own Technical Notices and have continued to update them which included making changes following the agreement to extend the UK’s membership of the European Union until 31 October. Those changes took place on the 11 April 2019. The Government continues to prepare for all Brexit scenarios.</p><p> </p> answering member constituency Braintree answering member printed James Cleverly question first answered 24/06/2019 16:44:26 answering member 4366 label Biography information for James Cleverly
tabling member	4077 label Biography information for Emma Reynolds

1132430

registered interest
date	17/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pathology: Vacancies
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the level of vacancy is in histopathology departments.
tabling member constituency	Totnes
tabling member printed	Dr Sarah Wollaston
uin	265511
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>NHS Improvement publishes vacancy data for three staff groups; doctors, nurses and ‘other staff’. These vacancy statistics are published for England and at the regional level of North, Midlands and East, London and South.</p><p>They do not specifically produce vacancy data for histopathology departments or any vacancy data for each National Health Service hospital or trust.</p><p>NHS Digital published the latest NHS Improvement vacancy data which can be found in the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-vacancies-survey/february-2015---march-2019-provisional-experimental-statistics</a></p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/06/2019 13:12:02 answering member 1585 label Biography information for Stephen Hammond
tabling member	4073 label Biography information for Dr Sarah Wollaston

1132499

registered interest
date	17/06/2019
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Customs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, what estimate his Department has made of the number of forms hauliers travelling from the UK to the EU would be required to submit daily to maintain current levels of trade with the EU in the event of full customs formalities at the border if the UK leaves the EU without a deal.
tabling member constituency	Cardiff Central
tabling member printed	Jo Stevens
uin	265544
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>It will be for exporters to the EU, rather than hauliers moving the goods, to submit export declarations and any associated documentation to HMG.</p><p> </p><p>However, to ensure that the goods are being legally exported, hauliers will need to check with the trader that the goods have received ‘permission to progress’ to the port from HMRC before taking them across the border.</p><p> </p><p>Hauliers should check with the relevant EU Member State to find out what forms are required to import into the EU.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 20/06/2019 13:28:55 answering member 3991 label Biography information for Jesse Norman
tabling member	4425 label Biography information for Jo Stevens

1131720

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many women who self referred for an abortion in a (a) British Pregnancy Advisory Service and (b) Marie Stopes International clinic were certified for abortion by two doctors whilst in that clinic in the last 12 months for which information is available; and if he will make a statement.
tabling member constituency	Southend West
tabling member printed	Sir David Amess
uin	263655
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>This information is not collected centrally.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 20/06/2019 13:19:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	44 label Biography information for Sir David Amess

1131740

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which topics have been identified for inclusion in the upcoming review of the appraisal methods used by NICE.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	263870
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263871 263872 263873 263874 question first answered 20/06/2019 13:18:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4382 label Biography information for Daniel Zeichner

1131742

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for NICE's Methods review.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	263871
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263870 263872 263873 263874 question first answered 20/06/2019 13:18:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4382 label Biography information for Daniel Zeichner

1131743

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether changes to NICE’s appraisal methods identified during the NICE Methods review will be cost-neutral.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	263872
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263870 263871 263873 263874 question first answered 20/06/2019 13:18:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4382 label Biography information for Daniel Zeichner

1131744

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria was used by NICE to determine which patient organisations were offered membership of the NICE Methods Working Group.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	263873
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263870 263871 263872 263874 question first answered 20/06/2019 13:18:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4382 label Biography information for Daniel Zeichner

1131746

registered interest
date	12/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	National Institute for Health and Care Excellence
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what opportunities there will be for patient groups that are not part of the NICE Methods Working Group to take part in the task and finish groups.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	263874
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for the methods and processes used in the development of its technology appraisal and highly specialised technologies recommendations. NICE has now initiated the review of its technology appraisal and highly specialised technologies methods in line with the commitment made in the 2019 Voluntary Scheme for Branded Medicines Pricing and Access.</p><p> </p><p>The Voluntary Scheme states that industry and other relevant stakeholders will be active participants in the review, including inputting on scope, participating in working discussions, and providing views on recommendations. NICE’s updated methods guide will also be subject to a public consultation.</p><p> </p><p>NICE has established a working group, consisting of members from NICE, NHS England, the Department, patient organisations and the life sciences industry. The working group reports to a steering group, chaired by NICE and with members from NHS England, the Department, and an independent academic methodologist. The steering group will present its recommendations to NICE’s Senior Management Team, which in turn will report to the NICE Board. NICE approached patient groups with experience of NICE and its processes and methods. There are three patient group representatives on the working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Membership of the working group will be published in due course.</p><p> </p><p>NICE is now in the process of scoping the review of the methods for technology appraisal and highly specialised technologies evaluations with input from the working group and steering group. The scope of the review - a list of the aspects of NICE’s current methods that will be considered in the review - will be presented to the NICE Board in July. Additional detail and more information will be made available on the NICE website in due course. NICE anticipates being in a position to confirm the revised methods guide by the end of 2020, following public consultation.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 263870 263871 263872 263873 question first answered 20/06/2019 13:18:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	4382 label Biography information for Daniel Zeichner

1131829

registered interest
date	12/06/2019
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Electric Vehicles: Vans
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps his Department is undertaking with industry to support the production of electric vans in the UK.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	263691
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>The Government’s mission is to put the UK at the forefront of the design and manufacturing of zero emission vehicles, and for all new cars and vans to be effectively zero emission by 2040. There are a number of manufacturers already producing vans in the UK or with ambitious plans to begin production in coming years. The Government’s Office for Low Emission Vehicles (OLEV) offers a comprehensive package of support for ultra-low emission vehicles (ULEVs). This will see nearly £1.5bn invested in total over the period 2015-2021.</p><p> </p><p>In order to ensure the development of new technologies happens in the UK, OLEV has awarded over £300m in grants via Innovate UK, supporting vehicle manufacturers, technology companies and academia in delivering a major programme of R&amp;D into ULEVs, including vans.</p><p> </p><p>In order to incentivise the purchase of ULEV vans, grant funding has been available since 2012. The plug-in van grant provides 20% of the price of a qualifying vehicle to a maximum grant amount of £8,000, or £20,000 for the first 200 large vans (3.5t+) or trucks, and will be available in some form until at least 2020. Our grant funding for chargepoint infrastructure in homes, at workplaces and on residential streets, as well as the upcoming Charging Infrastructure Investment Fund, all support charging infrastructure for ultra-low emission vans.</p><p> </p><p>In order to aggregate demand for these vans, Government has focused on the biggest fleets. Working with environmental NGO Global Action Plan, 27 of the UK’s largest van fleet operators have joined the Clean Van Commitment committing to transition their total fleet of 65,000 vans to electric by 2028. Again, to support demand, we have legislated to increase the weight allowance for certain alternatively fuelled vans that drivers can drive on a standard Category B driving licence. This is designed to mitigate the additional weight alternatively fuelled power trains can add and avoid the payload of vans being affected.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/06/2019 13:14:35 answering member 4044 label Biography information for Andrew Stephenson
tabling member	318 label Biography information for Lord Spellar